Targeting genotoxic and proteotoxic stress-response pathways in human prostate cancer by clinically available PARP inhibitors, vorinostat and disulfiram-Reference-Cited by-同舟云学术

Targeting genotoxic and proteotoxic stress-response pathways in human prostate cancer by clinically available PARP inhibitors, vorinostat and disulfiram

Published:2018-11-29 Issue:4 Volume:79 Page:352-362
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Majera Dusana¹^ORCID,Skrott Zdenek¹,Bouchal Jan²^ORCID,Bartkova Jirina³⁴,Simkova Dana²,Gachechiladze Mariam²,Steigerova Jana²,Kurfurstova Daniela²,Gursky Jan¹,Korinkova Gabriela²,Cwiertka Karel⁵,Hodny Zdenek⁶,Mistrik Martin¹,Bartek Jiri¹³⁴⁶

Affiliation:

1. Laboratory of Genome Integrity, Institute of Molecular and Translational Medicine; Faculty of Medicine and Dentistry, Palacky University; Olomouc Czech Republic

2. Department of Clinical and Molecular Pathology; Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University; Olomouc Czech Republic

3. Danish Cancer Society Research Center; Copenhagen Denmark

4. Division of Genome Biology, Department of Medical Biochemistry and Biophysics; Science for Life Laboratory, Karolinska Institute; Stockholm Sweden

5. Department of Oncology, Faculty of Medicine and Dentistry; Palacky University, University Hospital; Olomouc Czech Republic

6. Department of Genome Integrity; Institute of Molecular Genetics of the CAS, v.v.i.; Prague Czech Republic

Funder

The Danish cancer society

the Novo Nordisk Foundation

Palacky University

the Swedish research council and Cancer Fonden

the Danish council for independent research

Czech Ministry of Education

Czech National Program of Sustainability